Stockscreener 앱 받기
1.17
0.00%
0.01
전일 마감가:
$1.16
열려 있는:
$1.14
하루 거래량:
83,011
Relative Volume:
0.20
시가총액:
$31.49M
수익:
$950.10K
순이익/손실:
$-16.69M
주가수익비율:
-1.4096
EPS:
-0.83
순현금흐름:
$-15.16M
1주 성능:
+0.00%
1개월 성능:
-2.52%
6개월 성능:
-3.33%
1년 성능:
-10.08%
1일 변동 폭
$1.14
$1.17
1주일 범위
$1.12
$1.2079
52주 변동 폭
$0.86
$1.80
Femasys Inc Stock (FEMY) Company Profile
명칭
Femasys Inc
전화
770-500-3910
주소
3950 JOHNS CREEK COURT, SUWANEE
FEMY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
1.17 | 31.49M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
534.30 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
168.16 | 48.46B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
97.94 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
240.96 | 35.24B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.08 | 16.39B | 3.90B | 392.30M | 288.10M | 1.95 |
Femasys Inc 주식(FEMY)의 최신 뉴스
Geode Capital Management LLC Acquires 9,681 Shares of Femasys Inc. (NASDAQ:FEMY) - Defense World
Femasys Inc. (NASDAQ:FEMY) Sees Significant Drop in Short Interest - Defense World
Femasys (NASDAQ:FEMY) Stock Price Down 3.2% – Time to Sell? - Defense World
FEMY’s 52-Week Rollercoaster: From $0.86 to $1.80 – What’s Next for Investors? - investchronicle.com
FemBloc Delivery System Approved by European Regulators - Medical Product Outsourcing
Femasys Reports Wider-Than-Expected Annual Loss, But Retail Continues To Be Optimistic - Asianet Newsable
HC Wainwright Reaffirms “Buy” Rating for Femasys (NASDAQ:FEMY) - Defense World
Femasys Positioned for Growth with Innovative Products and Strategic Partnerships - TipRanks
H.C. Wainwright maintains Femasys stock Buy rating, $15 target By Investing.com - Investing.com India
H.C. Wainwright maintains Femasys stock Buy rating, $15 target - Investing.com
Femasys Positioned for Growth in 2025 with Strategic Partnerships and Regulatory Progress - TipRanks
Femasys Inc. (FEMY) Reports Q4 Loss, Lags Revenue Estimates - MSN
Femasys earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
Femasys reports FY24 EPS (85c), consensus (81c) - TipRanks
Femasys Inc. FY EPS USD -0.85 - Marketscreener.com
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update - GlobeNewswire
FEMASYS Earnings Preview: Recent $FEMY Insider Trading, Hedge Fund Activity, and More - Nasdaq
FY2026 Earnings Forecast for Femasys Issued By HC Wainwright - Defense World
HC Wainwright Raises Femasys (NASDAQ:FEMY) Price Target to $15.00 - The AM Reporter
HC Wainwright Boosts Femasys (NASDAQ:FEMY) Price Target to $15.00 - Defense World
H.C. Wainwright raises Femasys stock price target to $15 By Investing.com - Investing.com Australia
Femasys price target raised to $15 from $12 at H.C. Wainwright - Yahoo Finance
H.C. Wainwright raises Femasys stock price target to $15 - Investing.com
Femasys (FEMY) to Release Earnings on Thursday - Defense World
Femasys Gains Momentum with EU Approval and Strategic Partnerships, Boosting Buy Rating - TipRanks
Femasys Announces Partnership with CNY Fertility, National - GlobeNewswire
Femasys Secures Game-Changing Partnership: FemaSeed Now Available at 11 Leading Fertility Centers - StockTitan
Femasys’s Strategic Expansion and Promising Clinical Results Justify Buy Rating - TipRanks
Assessing Femasys: Insights From 4 Financial Analysts - Benzinga
Femasys Signs FemBloc Commercial Distribution Deals -March 18, 2025 at 09:58 am EDT - Marketscreener.com
Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain - GlobeNewswire
Femasys Breaks Into European Market: First Global Deal for Revolutionary Birth Control Solution - StockTitan
HC Wainwright Reiterates “Buy” Rating for Femasys (NASDAQ:FEMY) - Defense World
H.C. Wainwright maintains Femasys stock Buy rating, $12 target By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Femasys stock Buy rating, $12 target - Investing.com
Femasys gains CE mark for non-surgical birth control system By Investing.com - Investing.com Australia
Femasys Achieves CE Mark for FemBloc, Paving the Way for European Market Entry and Justifying Buy Rating - TipRanks
Femasys Receives CE Mark for FemBloc Non-Surgical Permanent Birth Control System - Femtech Insider
Femasys Inc (FEMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
0.11%
자본화:
|
볼륨(24시간):